The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

CDDF Multi-stakeholder Workshops in 2024

Save the date for the CDDF Multi-Stakeholder workshops in 2024!

CANCER DRUG DEVELOPMENT FORUM

The leading non-competitive drug development platform working to
stimulate the advancement and accessibility of cancer treatment.

[🔔 📢 Key Takeaways from the CDDF Webinar on “Cancer Medicines Forum: Advancing Cancer Treatment Optimization Across Europe”]

The Cancer Drug Development Forum (CDDF) held a live webinar on Cancer Medicines Forum on 25 June 2024. In this webinar, Denis Lacombe (EORTC, BE) provided an interesting talk followed by a Q&A discussion moderated by Rosa Giuliani (CDDF, UK) and Daniel Goldstein...

ACT EU: Materials from MSP AG Meeting – 4 July 2024

Check out presentation slides from the MSP AG Meeting that took place on 4 July 2024 and stay up to date on topics of interest for clinical trials in the EU. Multi-stakeholder platform - European Union (europa.eu)

ACT EU: Faster Access to Clinical Trial Information in Europe

The launch of a new version of the Clinical Trials Information System (CTIS) is giving earlier and more efficient access to clinical trial information in Europe. Revised transparency rules eliminate deferral mechanisms providing public access to approximately 4000...

ACT EU: Two New Advice Pilots to Improve Clinical Trials in Europe

On 10 June 2024, the Accelerating Clinical Trials in the EU (ACT EU) initiative launched two advice pilots aimed at improving the quality of applications for clinical trials, the foundation for the development of safe and effective medicines in Europe. For more...

Nomination of New Vice Chairperson: Professor Stefan Symeonides

The Cancer Drug Development Forum (CDDF) is delighted to announce that Professor Stefan Symeonides has been nominated as new Deputy Chairperson for a three-year term, succeeding Professor Eva Skovlund. This nomination took effect on 23 May 2024 following the CDDF...

Warm Welcome for PharmaMar to the CDDF Multi-Stakeholder Community

🎉 📣 The Cancer Drug Development Forum (CDDF) is excited to introduce our new Industry member, PharmaMar, who will make collaborative efforts with the CDDF in order to improve the healthcare outcomes of cancer patients. PharmaMar is a unique company as a pioneer of...

[Multi-stakeholder Interview: Get an Inside Look at the CDDF Multi-Stakeholder Discussion on Clinical Research in Central and Eastern Europe]

The Cancer Drug Development Forum (CDDF) is excited to share interview clips featuring a diverse group of stakeholders from our recent Multi-Stakeholder Workshop on Clinical Research in Central and Eastern Europe. Held in Krakow, Poland on 15-16 April 2024, the...

🔔 📣 NEW PUBLICATION: Executive Summary: CDDF Multi-Stakeholder Workshop on Clinical Research in Central and Eastern Europe (15-16 April 2024, PL)

The Cancer Drug Development Forum (CDDF) is delighted to announced that the executive summary of its recent workshop on Clinical Research in Central and Eastern Europe has been published today and is available to all our stakeholders.  This workshop took place on 15-...

Warm Welcome for Arvinas to the CDDF Multi-Stakeholder Community

🎉 📣 [Warm Welcome for Arvinas to the CDDF Multi-Stakeholder Community] The Cancer Drug Development Forum (CDDF) is excited to introduce our new Industry member, Arvinas, who will make collaborative efforts with the CDDF to improve cancer drug development. Arvinas is...

NEW PUBLICATION-INTERVIEW ARTICLE: Collaboration and Partnerships in Accelerating Cancer Drug Development

The Cancer Drug Development Forum (CDDF) is delighted to announce that Prof. Jaap Verweij and Prof. Ruth Plummer’s article, “Collaboration and Partnerships in Accelerating Cancer Drug Development” has been published in the April edition of Open Access Government. In...

CDDF Webinar: Bayesian Approaches in Drug Development (July 2024)

The recording of the recent CDDF webinar on Bayesian Approaches in Drug Development is available here. Enjoy the insightful talks from DRob Hemmings (Consilium, UK) followed by an interactive Q&A session.

CDDF & Oncology News

Check out the recent updates within the CDDF and the latest news in the community of cancer research

CDDF Brochure

Access the CDDF Brochure here

 

Join the CDDF community to find ways to accelerate oncology drug development and deliver optimal treatment to cancer patients

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752

info@cddf.org
Tel: +32 2 880 62 70